First-trimester increased nuchal translucency a prenatal sign of Zellweger syndrome [2]

Prenatal Diagnosis

Volumn 24, Issue 2, 2004, Pages 151-153

  Strenge, S ^a   Froster, U G ^a   Wanders, R J A ^b   Gartner, J ^c   Maier, E M ^d   Muntau, A C ^d   Faber, R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VERY LONG CHAIN FATTY ACID;

ADULT; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHORION VILLUS SAMPLING; CROWN RUMP LENGTH; FAMILY HISTORY; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; HUMAN; KARYOTYPE; LETTER; MALE; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; ZELLWEGER SYNDROME;

ADULT; CHORIONIC VILLI SAMPLING; FEMALE; FETAL DISEASES; HUMANS; INFANT; MALE; NECK; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL; ZELLWEGER SYNDROME;

EID: 1542351155     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.805     Document Type: Letter

References (13)

1. Bilardo CM, Pajkrt E, de Graaf I, Mol BW, Bleker OP. 1998. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 11: 401-406.
2. Brosius U, Gartner J. 2002. Cellular and molecular aspects of Zellweger syndrome and other peroxisome biogenesis disorders. Cell Mol Life Sci 59: 1058-1069.
3. Christiaens GCML, de Pater JM, Stoutenbeek P, Drogtrop A, Wanders RJA, Beemer FA. 2000. First trimester nuchal anomalies as a prenatal sign of Zellweger syndrome. Letter to the editor. Prenat Diagn 20: 520-521.
4. de Graaf IM, Pajkrt E, Keessen M, Leschot NJ, Bilardo CM. 1999. Enlarged nuchal translucency and low serum protein concentrations as possible markers of Zellweger syndrome. Ultrasound Obstet Gynecol 13: 268-270.
5. Hyett JA. 2002. Increased nuchal translucency in fetuses with a normal karyotype. Prenat Diagn 22: 864-868.
6. Johnson JM, Babul-Hirji R, Chitayat D. 2001. First-trimester increased nuchal translucency and fetal hypokinesia associated with Zellweger syndrome. Ultrasound Obstet Gynecol 17: 344-346.
7. Roscher A, Molzer B, Bernheimer H, Stockler S, Mutz I, Paltauf F. 1985. The cerebrohepatorenal (Zellweger) syndrome: an improved method for the biochemical diagnosis and its potential value for prenatal detection. Pediatr Res 19: 930-933.
8. Souka AP, Snijders RJM, Novakov A, Soares W, Nicolaides KH. 1998. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 11: 391-400.
9. Steinberg SJ, Elcioglu N, Slade CM, et al. 1999. Peroxisomal disorders: Clinical and biochemical studies in 15 children and prenatal diagnosis in 7 families. Am J Med Genet 85: 502-510.
10. Van Vugt JMG, Tinnemans BWS, van Zalen-Sprock RM. 1998. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 11: 407-409.
11. Wanders RJA, Schutgens RBH, Barth PG. 1995. Peroxisomal disorders: a review. J Neuropathol Exp Neurol 54: 726-739.
12. Wanders RJA, Schutgens RBH, van den Bosch H, Tager JM, Kleijer WJ. 1991. Prenatal diagnosis of inborn errors in peroxisomal beta-oxidation. Prenat Diagn 11: 253-261.
13. Weller S, Gartner J. 2002. Peroxisomale Stoffwechselerkrankungen. Entwicklungsstörungen von Peroxisomen. Monatsschr Kinderheilkd 150: 226-237.